103 related articles for article (PubMed ID: 16989287)
1. Regulatory mechanisms for abnormal expression of the human breast cancer specific gene 1 in breast cancer cells.
Lu A; Li Q; Liu J
Sci China C Life Sci; 2006 Aug; 49(4):403-8. PubMed ID: 16989287
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequences.
Lu A; Gupta A; Li C; Ahlborn TE; Ma Y; Shi EY; Liu J
Oncogene; 2001 Aug; 20(37):5173-85. PubMed ID: 11526506
[TBL] [Abstract][Full Text] [Related]
3. Blockade of AP1 transactivation abrogates the abnormal expression of breast cancer-specific gene 1 in breast cancer cells.
Lu A; Zhang F; Gupta A; Liu J
J Biol Chem; 2002 Aug; 277(35):31364-72. PubMed ID: 12072430
[TBL] [Abstract][Full Text] [Related]
4. [Expression of BCSG1-siRNA in tumor transplants of human breast cancer cell line in nude mice].
Shen PH; Zhang W; Zhang YH; Zhang HX; Fan QX
Zhonghua Bing Li Xue Za Zhi; 2010 Oct; 39(10):691-4. PubMed ID: 21176537
[TBL] [Abstract][Full Text] [Related]
5. BCSG1 siRNA delivered by lentiviral vector suppressed proliferation and migration of MDA-MB-231 cells.
He JS; Xie N; Yang JB; Guan H; Chen WC; Zou C; Ouyang YW; Mao YS; Luo XY; Pan Y; Fu L
Int J Mol Med; 2018 Mar; 41(3):1659-1664. PubMed ID: 29286089
[TBL] [Abstract][Full Text] [Related]
6. [The effect of breast cancer specific gene 1 in the prognosis of breast cancer].
Wu KJ; Weng ZY; Lin GF; Wu XR; Li FM; Zhang YC
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(5):294-7. PubMed ID: 15842935
[TBL] [Abstract][Full Text] [Related]
7. BCSG1 methylation status and BCSG1 expression in breast tissues derived from Chinese women with breast cancer.
Gu YM; Tan JX; Lu XW; Ding Y; Han X; Sun YJ
Oncology; 2008; 74(1-2):61-8. PubMed ID: 18544996
[TBL] [Abstract][Full Text] [Related]
8. Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing.
Ji H; Liu YE; Jia T; Wang M; Liu J; Xiao G; Joseph BK; Rosen C; Shi YE
Cancer Res; 1997 Feb; 57(4):759-64. PubMed ID: 9044857
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1.
Gupta A; Inaba S; Wong OK; Fang G; Liu J
Oncogene; 2003 Oct; 22(48):7593-9. PubMed ID: 14576821
[TBL] [Abstract][Full Text] [Related]
10. Effects of the Methylation Levels for the Breast Cancer Associated Genes
Li J; Li P; Li J; Yang H; Liu G; Shen P; Jiang G
Genet Test Mol Biomarkers; 2022 Sep; 26(9):422-429. PubMed ID: 36166741
[No Abstract] [Full Text] [Related]
11. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.
Wu K; Quan Z; Weng Z; Li F; Zhang Y; Yao X; Chen Y; Budman D; Goldberg ID; Shi YE
Breast Cancer Res Treat; 2007 Mar; 101(3):259-67. PubMed ID: 16821081
[TBL] [Abstract][Full Text] [Related]
12. Multi-slice spiral CT evaluation of breast cancer chemotherapy and correlation between CT results and breast cancerspecific gene 1.
Li J; Gao W; Yu B; Wang F; Wang L
J BUON; 2018; 23(2):378-383. PubMed ID: 29745080
[TBL] [Abstract][Full Text] [Related]
13. Silencing of BCSG1 with specific siRNA via nanocarriers for breast cancer treatment.
Yang C; Cheng X; Shen P
Bull Cancer; 2021 Mar; 108(3):323-332. PubMed ID: 33423781
[TBL] [Abstract][Full Text] [Related]
14. Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.
Xie Y; Nakanishi T; Natarajan K; Safren L; Hamburger AW; Hussain A; Ross DD
Biochim Biophys Acta; 2015 Mar; 1849(3):317-27. PubMed ID: 25615818
[TBL] [Abstract][Full Text] [Related]
15. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
16. Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.
Anisowicz A; Sotiropoulou G; Sager R
Mol Med; 1999 Aug; 5(8):526-41. PubMed ID: 10501656
[TBL] [Abstract][Full Text] [Related]
17. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
18. MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines.
Ouatas T; Clare SE; Hartsough MT; De La Rosa A; Steeg PS
Clin Exp Metastasis; 2002; 19(1):35-42. PubMed ID: 11918081
[TBL] [Abstract][Full Text] [Related]
19. CREB-1 and AP-1 transcription factors JunD and Fra-2 regulate bone sialoprotein gene expression in human breast cancer cells.
Detry C; Lamour V; Castronovo V; Bellahcène A
Bone; 2008 Feb; 42(2):422-31. PubMed ID: 18088579
[TBL] [Abstract][Full Text] [Related]
20. Immune effect and safety evaluation of vaccine prepared by dendritic cells modified by rAAV-carrying BCSG1 gene.
Wang WH; Zhou CH; Ding J; Zhang YX; Zheng LL; Chen SF; Zhang W
Gene Ther; 2016 Dec; 23(12):839-845. PubMed ID: 27556816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
